Загрузка страницы

ARIES® SARS-CoV-2 Assay (CE-IVD)

The ARIES® SARS-CoV-2 Assay is a real time RT-PCR-based in vitro diagnostic test that qualitatively detects SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) samples in UTM™, Liquid Amies (ESwab™), or equivalent.

The ARIES® SARS‑CoV‑2 Assay (CE-IVD) offers:
• Fully Integrated Testing: Automate all aspects of testing, from sample preparation through analysis, in a self-contained cassette.
• Flexible Throughput: In two hours, process from 1 to 12 tests per batch; both STAT testing and medium volume sample batching are supported.
• A Versatile Portfolio: With a growing portfolio of cassette-ready assays and the tools to create laboratory developed tests (LDTs),* ARIES® Systems deliver reliable detection for a wide range of testing needs.
• Reliable Performance: In addition to sensitive detection of SARS-CoV-2 through the ORF1ab and N gene targets, a sample processing control included in the cassette confirms result validity.

Видео ARIES® SARS-CoV-2 Assay (CE-IVD) канала Luminex
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
17 апреля 2021 г. 2:42:26
00:02:07
Яндекс.Метрика